Clinical trials: Pancreatic Diseases
Pancreatic Neoplasms
Pancreatic Surgical Database
This data base has been set in order to gather medical and surgical information from patients who have undergone surgery for pancreatic cancer, at Institut Paoli Calmettes or Assistance Publique des Hôpitaux de Marseille, France.
- Trial name
- CHIRPAN (NCT02871336)
- Testing
- Data collection
- Where
- France
- Volunteers
- 1,500 people
- Sponsor
- Institut Paoli-Calmettes
Diabetes Mellitus, Pancreatic Cancer, Adult
Surveillance of Pancreatic Health After Diabetes Diagnosis
The goal of this interventional study is to evaluate if the novel diagnostic blood test, called Avantect can early detect pancreatic cancer in patients diagnosed with type 2 diabetes or with elevated sugar levels within the last…
- Trial name
- SAFE-D (NCT06803771)
- Testing
- Avantect Pancreatic Cancer Test
- Where
- 31 sites in United Kingdom
- Volunteers
- 5,000 people
- Sponsor
- University Hospital Southampton NHS Foundation Trust
Pancreatic Cancer
Feasibility Study of LUM Imaging System for Pancreatic Cancer
This single-site, non-randomized, open-label study to assess the initial safety and efficacy of the LUM Imaging System for detection of primary pancreatic cancer and peritoneal invasion from primary pancreatic cancer during…
- Trial name
- NCT04276909
- Testing
- LUM Imaging System
- Where
- United States
- Sponsor
- Lumicell, Inc.
Pancreatic Cancer
Role of Exosomes in Pancreatic Cancer Progression
The present pilot study is set up with the objective of identifying circulating markers in the biological fluids (blood and urine) of subjects with pancreatic carcinoma and their association with disease stage, to evaluate their…
- Trial name
- NCT06777030
- Where
- Italy
- Volunteers
- 60 people
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
Pancreatic Cyst
Usefulness of Contrast Enhanced Harmonic Endoscopic Ultrasound for Pancreatic Cysts
The study evaluates the role of contrast-enhanced harmonic endoscopic ultrasound (CH-EUS) for the differentiation of the pancreatic cysts and their malignant potential.
- Trial name
- NCT04389892
- Testing
- Contrast enhanced harmonic endoscopic ultrasound
- Where
- Romania
- Volunteers
- 58 people
- Sponsor
- Iuliu Hatieganu University of Medicine and Pharmacy
Advanced or Metastatic Solid Tumors, Triple Negative Breast Cancer (TNBC)
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
This is a Phase 1, first-in-human (FIH), open-label, multicenter study designed to evaluate the safety, tolerability, PK, and preliminary anti-tumor activity of SHY-ONC6 in participants with advanced or metastatic solid tumors…
- Conditions
- Advanced or Metastatic Solid Tumors, Triple Negative Breast Cancer (TNBC), HR+ Breast Cancer, Colon Cancer
- Trial name
- Luca-1 (NCT07705334)
- Testing
- SHY-ONC6
- Where
- 3 sites in United States
- Volunteers
- 30 people
- Sponsor
- SHY Therapeutics
Cystic Fibrosis, Pneumonia, Bacterial
Cefiderocol Pharmacokinetics in Adult Patients With Cystic Fibrosis
There is established evidence that adult patients with Cystic Fibrosis (CF) may have altered antibiotic pharmacokinetics compared with non-CF patients.
- Trial name
- NCT05314764
- Testing
- Cefiderocol
- Where
- 4 sites in United States
- Volunteers
- 10 people
- Sponsor
- Hartford Hospital
Pancreatic Cancer, Pancreatic Surgery
Surgery for Pancreatic Cancer With Oligo-Metastasis
Pancreatic cancer is increasing in incidence and will be the second leading cause of cancer-related deaths in 2030 in the West. Only 10 to 15% of patients are eligible for curative resection with long-term survival rarely…
- Trial name
- SPaM (NCT04196816)
- Where
- France
- Volunteers
- 200 people
- Sponsor
- University Hospital, Montpellier
Pancreatic Cancer, Cancer Cachexia
Florida Pancreas Collaborative Next Generation Biobank
The goal of this study is to partner with individuals known or suspected to have pancreatic cancer to build a biobank dedicated to minimizing disparities and personalizing care for individuals affected by pancreatic cancer.
- Trial name
- NCT03851133
- Testing
- Blood Sample Collection, Tumor Sample collection, Data Collection
- Where
- 14 sites in United States
- Volunteers
- 500 people
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
Type 1 Diabetes Mellitus
Feasibility Study of a Portable Artificial Pancreas System in Type 1 Diabetes Mellitus (T1DM) - Padova
A single arm, single treatment study is proposed to assess the feasibility of a portable artificial pancreas system outside of a hospital based clinical research center.
- Trial name
- HomeCTR1_2 (NCT01447992)
- Testing
- Portable artificial pancreas system with Control-To-Range
- Where
- Italy
- Volunteers
- 5 people
- Sponsor
- University of Virginia
Pancreatoduodenectomy
Neck Division Level and Postoperative Pancreatic Fistula After Pancreaticoduodenectomy
Brief Summary:* Aim of the study : To evaluate if the neck division level significantly influences the postoperative pancreatic fistula rate of pancreatico-jejunal anastomosis after pancreatoduodenectomy.
- Trial name
- PaNECK (NCT03850236)
- Where
- France
- Volunteers
- 196 people
- Sponsor
- University Hospital, Montpellier
Cystic Fibrosis
Alpha1 Antitrypsin Aerosol Therapy in Cystic Fibrosis
The hypothesis being tested is that inhibition of the enzyme known as elastase in the airways of patients with cystic fibrosis will help decrease the number of bacteria.
- Trial name
- NCT02010411
- Testing
- Prolastin (drug)
- Where
- Canada
- Volunteers
- 17 people
- Sponsor
- Université de Sherbrooke
Advanced Malignancies, Oncology
Phase 1/2a Study of RP-001 in Participants With Advanced Malignancies
Phase 1/2a Study of RP-001 in participants with Advanced Malignancies
- Conditions
- Advanced Malignancies, Oncology, Colorectal Cancer, Pancreatic Cancer
- Trial name
- NCT07504263
- Testing
- RP-001
- Volunteers
- 66 people
- Sponsor
- Recurv Pharma Inc
Pancreatic Neoplasms
Comparative Study of 22 and 25 Gauge ProCore EUS-guided Biopsy in Pancreatic Mass
Background: EUS-guided fine needle aspiration (FNA) is a major diagnostic tool in the patient with pancreatic mass with high specificity, specificity and accuracy.
- Trial name
- NCT01727921
- Testing
- 22 gauge ProCore needle biopsy, 25 gauge ProCore needle biopsy
- Where
- South Korea
- Volunteers
- 219 people
- Sponsor
- Samsung Medical Center
Pancreatic Cancer
Study of M2ES in Patients With Advanced Pancreatic Cancer After Gemcitabine Treatment Failure
The purpose of this study is to evaluate the safety and tolerability and determine the recommended dosing for the treatment in patients with advanced pancreatic cancer after fist-line Gemcitabine treatment failure.
- Trial name
- NCT01219192
- Testing
- M2ES, M2ES 60mg
- Where
- China
- Volunteers
- 24 people
- Sponsor
- Beijing Protgen Biotechnology Development Co., Ltd.
Colorectal Cancer, Pancreatic Cancer
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
The overall goal of this feasibility study is to assess the initial safety and efficacy of LUM015 in ex vivo far-red imaging of colorectal, pancreatic, and esophageal cancers (adenocarcinoma) using the LUM Imaging System.
- Conditions
- Colorectal Cancer, Pancreatic Cancer, Esophageal Cancer, Gastric Cancer
- Trial name
- NCT02584244
- Testing
- LUM015, LUM 2.6 Imaging Device
- Where
- United States
- Volunteers
- 66 people
- Sponsor
- Lumicell, Inc.
Cancer
BCX-1777 in Treating Patients With Refractory Cancer
RATIONALE: BCX-1777 may stop the growth of cancer cells by blocking the enzymes necessary for their growth. PURPOSE: Phase I trial to study the effectiveness of BCX-1777 in treating patients who have refractory cancer.
- Trial name
- NCT00073944
- Testing
- forodesine hydrochloride
- Where
- United States
- Sponsor
- BioCryst Pharmaceuticals
Pancreatic Cancer
Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma
The current study seeks to further investigate the impact of up-front systemic therapy in combination with fractionated SBRT for potentially resectable, locally-advanced pancreatic adenocarcinoma.
- Trial name
- NCT01360593
- Testing
- Gemcitabine, Capecitabine, Stereotactic Body Radiation Therapy (SBRT)
- Where
- United States
- Volunteers
- 35 people
- Sponsor
- David A. Clump, MD, PhD
KRAS-mutant Non-small Cell Lung Cancer (NSCLC), KRAS-mutant Pancreatic Ductal Adenocarcinoma (PDAC)
A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
The main purpose of the trial is to assess whether the trial drug, KST-6051, is safe and tolerable when administered orally, alone or in combination with other anticancer agents, to adults with advanced or metastatic solid tumors…
- Conditions
- KRAS-mutant Non-small Cell Lung Cancer (NSCLC), KRAS-mutant Pancreatic Ductal Adenocarcinoma (PDAC), KRAS-mutant Colorectal Cancer (CRC), Other KRAS-mutant Solid Tumors
- Trial name
- NCT07458347
- Testing
- KST-6051, Gemcitabine/nab-paclitaxel, Cetuximab
- Where
- 9 sites in United States
- Volunteers
- 545 people
- Sponsor
- Kestrel Therapeutics, Inc.
Pancreatic Cancer
A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Resectable Pancreatic Cancer
This is a single-center, single-arm, open investigator-initiated clinical study to evaluate the efficacy and safety of VRT106 in combination with chemotherapy in the treatment of resectable pancreatic cancer.
- Trial name
- NCT06758544
- Testing
- Oncolytic virus VRT106, Chemotherapy
- Where
- China
- Volunteers
- 18 people
- Sponsor
- Guangdong Provincial People's Hospital
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.